Project Grant HT94252310052
Award Date 12/30/22
Completion Date 12/29/25
Dollars Obligated $579K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
- The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420) and aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for the battlefield. The University...
- The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
- The Defense Health Agency awarded a $848,335 Project Grant to the University of Nebraska Medical Center (UNMC) on August 1, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 3-year research project to develop a novel therapeutic approach to prevent the progression of uveal melanoma, a rare and aggressive form of eye cancer. The project aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
- The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
- The University of Nebraska Medical Center (UNMC) was awarded a $183,220 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding will support research targeting the CCL17/CCR4 axis to eradicate lung cancer brain metastasis. The award period runs from February 1, 2025 to January 31, 2026. As a prominent academic research institution, UNMC leverages its expertise across medical sciences and advanced technologies to support...
- The Defense Health Agency awarded a $1,301,250.00 Project Grant titled "INHIBITING MDSC BIOGENESIS TO AUGMENT IMMUNOTHERAPY EFFICACY IN TRIPLE-NEGATIVE BREAST CANCER" to Health Research, Inc., a not-for-profit organization affiliated with the Roswell Park Comprehensive Cancer Center in Buffalo, New York. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military...
- The Defense Health Agency awarded a $1,204,746 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Old Dominion University Research Foundation (Odurf) for the project "Early Detection of Cancer Disparity and Treatment Resistance in TNBC". The grant, with a performance period from September 1, 2024 to January 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- The U.S. Department of Defense's Defense Health Agency has awarded a $466,234 Project Grant to the University of Queensland in Australia to conduct "PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC." This research grant, funded through the Military Medical Research and Development program (CFDA 12.420), aims to develop innovative treatments and diagnostic tools to improve care for military service members, veterans, and their...
- The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...